MoneyWorks4Me

The revenue declined to Rs. 1393.80 millions for the quarter ended March 2024 as compared to Rs. 1446.70 millions during the corresponding quarter last year.A comparatively good net profit growth of 28.62% to Rs. 698.80 millions was reported for the quarter ended March 2024 compared to Rs. 543.30 millions of previous same quarter.Operating profit surged to 938.60 millions from the corresponding previous quarter of 770.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1393.80 1446.70 -3.66 6250.90 5286.10 18.25 6250.90 5286.10 18.25
Other Income 361.80 122.20 196.07 1058.40 990.00 6.91 1058.40 990.00 6.91
PBIDT 938.60 770.90 21.75 3929.20 3189.20 23.20 3929.20 3189.20 23.20
Interest 0.20 0.30 -33.33 1.00 1.20 -16.67 1.00 1.20 -16.67
PBDT 938.40 770.60 21.78 3928.20 3188.00 23.22 3928.20 3188.00 23.22
Depreciation 69.30 62.90 10.17 270.80 256.50 5.58 270.80 256.50 5.58
PBT 869.10 707.70 22.81 3657.40 2931.50 24.76 3657.40 2931.50 24.76
TAX 170.30 164.40 3.59 820.30 588.90 39.29 820.30 588.90 39.29
Deferred Tax -1.90 -15.20 -87.50 -40.90 -76.90 -46.81 -40.90 -76.90 -46.81
PAT 698.80 543.30 28.62 2837.10 2342.60 21.11 2837.10 2342.60 21.11
Equity 151.90 151.80 0.07 151.90 151.80 0.07 151.90 151.80 0.07
PBIDTM(%) 67.34 53.29 26.37 62.86 60.33 4.19 62.86 60.33 4.19
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..